Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014. (Q38284466)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

1 reference

Europe PubMed Central

Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

0 references

Pneumocystis jirovecii

object named as

Pneumocystis jirovecii

1 reference

based on heuristic

inferred from title

author name string

L Cooley

1

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

C Dendle

2

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

J Wolf

3

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

B W Teh

4

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

S C Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

C Boutlis

6

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

K A Thursky

7

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

publication date

1 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Internal Medicine Journal

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

12b

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

1350-1363

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis carinii Pneumonia Among Patients Without AIDS at a Cancer Hospital

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Polymerase chain reaction detection of Pneumocystis jiroveci: evaluation of 9 assays.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

PCR diagnosis of Pneumocystis pneumonia: a bivariate meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic review

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: clinical significance of quantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

HRCT-features of Pneumocystis jiroveci pneumonia and their evolution before and after treatment in non-HIV immunocompromised patients

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis jiroveci pneumonia: high-resolution CT findings in patients with and without HIV infection

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Comparison of clinical and radiological features of pneumocystis pneumonia between malignancy cases and acquired immunodeficiency syndrome cases: a multicenter study.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis pneumonia in patients with HIV infection: clinical manifestations, laboratory findings, and radiological features

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis jiroveci pneumonia detected by FDG-PET.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

African american primary care physicians' prostate cancer screening practices

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncol

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis carinii pneumonia. Review of 53 cases

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Interstitial pneumonitis caused by Pneumocystis jirovecii pneumonia (PCP) during bortezomib treatment

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis carinii pneumonia complicating multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma receiving chemotherapy containing rituximab.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Increased incidence of interstitial pneumonia by CHOP combined with rituximab

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

A resurgence of Pneumocystis in aggressive lymphoma treated with R-CHOP-14: the price of a dose-dense regimen?

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Concerns regarding data supporting recent Pneumocystis jirovecii prophylaxis guidelines

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis carinii pneumonia in patients with primary brain tumors

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM).

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Does trimethoprim-sulfamethoxazole prophylaxis for HIV induce bacterial resistance to other antibiotic classes? Results of a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Dihydropteroate synthase polymorphisms in Pneumocystis carinii

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone).

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Intravenous pentamidine is safe and effective as primary pneumocystis pneumonia prophylaxis in children and adolescents undergoing hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Prevention and treatment of pneumocystis pneumonia

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Outcomes of moderate-to-severe Pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Cell wall assembly by Pneumocystis carinii. Evidence for a unique gsc-1 subunit mediating beta -1,3-glucan deposition

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Is caspofungin really an effective treatment for Pneumocystis jirovecii pneumonia in immunocompromised patients without human immunodeficiency virus infection? Experiences at a single center and a literature review.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Combined trimethoprim and caspofungin treatment for severe Pneumocystis jiroveci pneumonia in a five year old boy with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Nosocomial Pneumocystis jirovecii pneumonia: lessons from a cluster in kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Possible nosocomial transmission of Pneumocystis jirovecii

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

A cluster of Pneumocystis infections among renal transplant recipients: molecular evidence of colonized patients as potential infectious sources of Pneumocystis jirovecii

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Pneumocystis jirovecii in general population

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Immunocompetent hosts as a reservoir of pneumocystis organisms: histological and rt-PCR data demonstrate active replication

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Molecular epidemiology linking multihospital clusters of opportunistic Pneumocystis jirovecii pneumonia

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FIMJ.12599

21 January 2018

Identifiers

10.1111/IMJ.12599

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38284466&oldid=1624777225"